Rigassi Lisa, Popa Mirel Adrian, Stiller Ruth, Leeners Brigitte, Rosselli Marinella, Dubey Raghvendra Krishna
Department of Reproductive Endocrinology, University Hospital Zurich, 8952 Schlieren, Switzerland.
Institute of Cellular Biology and Pathology Nicolae Simionescu, Romanian Academy, 050568 Bucharest, Romania.
Cells. 2025 Jul 23;14(15):1134. doi: 10.3390/cells14151134.
Estrogens regulate many physiological processes in the human body, including the cardiovascular system. Importantly, Estradiol (E2) exerts its vascular protective actions, in part, by promoting endothelial repair via induction of endothelial cell (EC) proliferation, migration and angiogenesis. Recent evidence that microRNAs (miRNAs) play an important role in vascular health and disease as well as in regulating Estrogen actions in many cell types. We hypothesize that E2 may mediate its vascular protective actions via the regulation of miRNAs. Following initial screening, we found that E2 downregulates the levels of miR-193a-3p in ECs. Moreover, miR-193a-3p downregulation by miR-193a-3p-antimir mimicked the effects as E2 on EC growth, migration, and capillary formation. Restoring miR-193a-3p levels with mimics after E2 treatment abrogated the vasculogenic actions of E2, suggesting a key role of miR-193a-3p in E2-mediated EC-growth-promoting effects. We further investigated the cellular mechanisms involved and found that miR-193a-3p inhibits angiogenesis by blocking phosphoinositide-3-kinase (PI3K)/Akt-vascular endothelial growth factor (VEGF) and Activin receptor-like kinase 1 (ALK1)/SMAD1/5/8 signaling in ECs, both pathways that are important in E2-mediated vascular protection. Additionally, using reverse transcription polymerase chain reaction (RT-PCR), we demonstrate that E2 downregulates miR-193a-3p in ECs via Estrogen Receptor (ER)α, but not ERβ or G protein-coupled estrogen receptor (GPER). Moreover, these actions occur post-transcriptionally, as the expression of pri-miR-193a-3p was not affected. The anti-angiogenic actions of miR-193a-3p were also observed in in vivo Matrigel implant-based capillary formation studies in ovariectomized mice where E2 induced capillary formation, and these effects were abrogated in the presence of miR-193a-3p, but not in the control mimic. Assessment of miR-193a-3p levels in plasma collected from in vitro fertilization (IVF) subjects with low and high E2 levels showed significantly lower miR-193a-3p levels in responders during the high E2 period. Hence, our findings provide the first evidence that miR-193a-3p mimic inhibits angiogenesis whereas its antimir is angiogenic. Importantly, E2 mediates its regenerative actions on ECs/capillary formation by downregulating endogenous miR-193a-3p expression. Both miR-193a-3p mimic or antimir may represent important therapeutic molecules to prevent or to induce endothelial function in treating pathophysiologies associated with capillary growth.
雌激素调节人体中的许多生理过程,包括心血管系统。重要的是,雌二醇(E2)发挥其血管保护作用,部分是通过诱导内皮细胞(EC)增殖、迁移和血管生成来促进内皮修复。最近有证据表明,微小RNA(miRNA)在血管健康和疾病以及调节许多细胞类型中的雌激素作用方面发挥着重要作用。我们假设E2可能通过调节miRNA来介导其血管保护作用。经过初步筛选,我们发现E2下调了ECs中miR-193a-3p的水平。此外,miR-193a-3p拮抗剂下调miR-193a-3p模拟了E2对EC生长、迁移和毛细血管形成的影响。E2处理后用模拟物恢复miR-193a-3p水平消除了E2的血管生成作用,表明miR-193a-3p在E2介导的促进EC生长的作用中起关键作用。我们进一步研究了其中涉及的细胞机制,发现miR-193a-3p通过阻断ECs中的磷酸肌醇-3-激酶(PI3K)/Akt-血管内皮生长因子(VEGF)和激活素受体样激酶1(ALK1)/SMAD1/5/8信号通路来抑制血管生成,这两条通路在E2介导的血管保护中都很重要。此外,使用逆转录聚合酶链反应(RT-PCR),我们证明E2通过雌激素受体(ER)α而非ERβ或G蛋白偶联雌激素受体(GPER)下调ECs中的miR-193a-3p。而且,这些作用发生在转录后,因为pri-miR-193a-3p的表达不受影响。在基于基质胶植入的去卵巢小鼠体内毛细血管形成研究中也观察到了miR-193a-3p的抗血管生成作用,其中E2诱导了毛细血管形成,而在存在miR-193a-3p的情况下这些作用被消除,但在对照模拟物存在时未被消除。对体外受精(IVF)受试者在E2水平低和高时采集的血浆中miR-193a-3p水平的评估显示,在E2水平高的时期,反应者的miR-193a-3p水平显著降低。因此,我们的发现提供了首个证据,即miR-193a-3p模拟物抑制血管生成,而其拮抗剂具有促血管生成作用。重要的是,E2通过下调内源性miR-193a-3p表达来介导其对ECs/毛细血管形成的再生作用。miR-193a-3p模拟物或拮抗剂都可能代表重要的治疗分子,用于预防或诱导内皮功能,以治疗与毛细血管生长相关的病理生理过程。